Carnitine palmitoyltransferase 1B (CPT1B), a crucial enzyme of long-chain fatty acid β-oxidation and also a member of the PPAR pathway, has been found to be underexpressed in high-grade BLCA. This evidence concerns the gene CPT1B and bladder transitional cell carcinoma.